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Tenascin-C is a large hexam.eric extracellular 1natrix 
glycoprotein that is expressed in a temporally and 
spatially restricted pattern associated with stromal-
epithelial interactions. In adult human skin, the ex-
pression level of tenascin-C is low, but tenascin-C is 
abundantly present in the dermal compartment dur-
ing embryogenesis and wound healing and in skin 
tumors. Herein we have investigated the cellular 
source oftenascin-C production in human skin, both 
in I'il'o and itlvitl'O, by using immunohistochemistry, 
mRNA it! situ hybridization, western blotting, and an 
enzyme-linked immunosorbent assay. In addition we 
studied the cell-matrix interaction between epider-
mal keratinocytes and purified tenascin-C. By using 
ill l'itl'O culture models, we found that keratinocytes 
not only synthesize and secrete tenascin-C but can 
also deposit tenascin-C in de-epidermized dermis in a 
T enascin-C is a large hexameric extn lcellular matI"ix glycoprotein consisting of subunits of 220 -320 kDa that are linked by disulfide bonds (for review see Schenk and C hiquet Elu:ism ann , 1994; C hiquet Bhrismann el nl, 1994; and LightJ1er, 1994). T he 
tenascin-C subunits ha ve a modular structure, in humans forming a 
cysteine-rich domain at the N terminus, followed by 14.5 domains 
with homology to epidermal growth factor, a number of fibron ec-
tin type III repeats (varying fi'ol11 9 to 16 as a result of alternative 
splicing of tenascin-C RNA), and a fibrinogen-like domain at the C 
terrl1.inus. R ecentl y, two proteins with the sam e general strLlC[Lue 
have been described, named tenascin-R (or restrictin) and tenas-
cin-X . In analogy, tenascin is ca lled tenascin-C in more recent 
literature, where the C stands for cytotactin , a synonym for 
tenascin. 
Tenascill-C is abundan t during embryogenesis, particularly at 
mesenchymal- epithelial illteraction sites (Crossin et nl, 1986; 
Aufderheide et nl, 1987; Aufderheide and Bkblom, 1988; BkbJol11 
and Aufderheide, 1989; Vainio et nl, 1989; C hua ng et nl, 1991), but 
expression is limited in adult ti ssues. In normal skin tenascin-C is 
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pattern that is very similar to that i1l llivo. III "ivD, 
during wound healing of normal human skin, we 
found tenascin-C extracellularly in the wound bed 
and also in a granular pattern within the neo-epider-
mis. By mRNA in sitlt hybridization, we could identify 
the basal migrated keratinocytes as the 1nain source 
of tenascin-C in the early phase of wound healing. In 
the granulation phase, tenascin-C expression by the 
Iteratinocytes is downregulated. Cultured keratino-
cytes were found to adhere poorly to tenascin-C, and 
those that did adhere retained a rounded morphol-
ogy. We conclude that human keratinocytes arC a 
major source of tenascil1-C during the early phase of 
wound healing, and we hypothesize that tenascin-C 
is unlikely to be an adhesive substrate for 1nigrating 
keratinocytes. Key words: in situ itybl'idizatioll/epitileli-
IIIIl/cell adhesion. ] Invest Derma.toi 108:776-783, 1997 
detected in the dermis, where it is sparsely distributed at the 
derm al-epidermal junction and slIrl'Ounds blood vessels and epi-
dermal adnexa (Lightner et nl, 1989; Schalkwijk el (II, 1991 b; 
Shikata el ai, 1994). Tn conditions of epidermal hyper-proliferation, 
such as psoriasis (Schalkwijk el nl, 1991 b) , epidermal tumors 
(Stamp, 1989 ; SchalkwUk el nl, 1991b; Verstraeten et nl, 1992; 
Shikata et ai, 1994), and injury (Schalkwijk el ai, 1991a; Betz el ai, 
1993; Juhasz el nl, 1993; Latijnhouwers el nl, 1996), te nascin-C 
expression in the papillary dennis i.s strongly upregulated. T he role 
of tenascin-C il/. J);'/O is stLll a matter of debate. III J)ilm studies have 
suggested variolls functions for tenascin-C , including modulation 
of cell proliferation and cell adhesion (Chigu et Bhrismann et ai, 
1988; Friedlander el nl, 1988; Lotz el nl, 1989; Spring e/ nl, 1989: 
Lightner and Erickson, 1990; .Murphy Ullrich et nl, 1991; Ptieto eI 
ai, 1992, 1993) and suppression of the i.mmune response (Ruegg el 
nl, 1989; Hel11esath et ai, 1994). Knocking out the lel1!1scil1-C gene in 
mice, however , does not induce marked phenotypic changes. 
Whether the tenascin-C-l ike m olecules tenascill-R and tenascin-X 
in these knock-out mice take over the functions that are normally 
exhibited by tenascin-C is not yet clear. 
For many ti ssues, reports pointed to mesenchymal cells as the 
cellular sourCe of ten<lscin-C, whereas epi the.1ial cells induce or 
modulate tcna scill-C production. When mesenchym e is co-cul-
tured with epi thelial cells, for example, m esenchymal tenascill-C 
expression is induced (Aufderheide and Ekblom, 1988; Inaguma er 
nl, 1988). III vivo, increase in m esenchymal tenascil1-C also cone-
lates with epitheljal changes, notably epidermal hyper-proliferation 
in skin (Stamp, 1989; Schalkwijk el 111 , 1991<1, 1991b; V erstraeten eI 
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ai, 1992; Betz el ai, 1993 ; Juhasz el ai, 1993; Shikata el ai, 1994; 
Latijuhouwers et ai, 1996). COllsequently, epidermal keratinocytes 
were considered to merely stimulate tenascin-C production of 
dermal fibroblasts in skin, More recently, however, epithelial cells 
were reported to produ ce tenascin-C as w ell. Cells may secrete 
tenascin-C only when cultured ill "ill"o (Kawakatsu et ai, 1992) and 
not after injection in nude mice (Sakai el ai, 1993), although the 
opposite is possible as well (Hiraiwa el ai, 1993). Iml11unohisto-
chemically, ten3scin-C was detected in developing corneal epithe-
lium (Kaplony el ai, 1991) , epithelial lung tumor cells (Soini el ai, 
, 1993), human amnion cells (Linn ala e/ ai, 1993), and human breast 
tissue (Lightner el ai, 1994) . It should be noted, however, that the 
extracellular localiza tion of tenascin-C hampers the immunohis to-
chemical identifi cation of cells expressing tenascin- C. III sitll hy-
bridization is the preferred approach to identify the cellular source 
of tenascin-C. By ill sitll hybridization, tenascin-C mRNA was 
detected in the epithelium of developing bronchi (Prieto el ai, 1990; 
Koch el ai, 1991) in normal and malignant breast epithelium 
(Lightner c/ ai, 1994) and cornea (Tucker, 1991). In the epitllelium 
of developing chicken feather buds, however, no tenascin-C 
mRNA was found (Prieto e/ ai, 1990). These findings of epithelial 
tenas cin-C expression led us to fu rther examine tenascin-C expres-
sion in skin, Our data demonstrate that epidermal keratinocytes 
secrete tenascin-C and deposit tenascin- C in the extracellular 
matrix ill lI ilro and ill lIillO during wound healing. In addition we 
investigated the effect of tenascin-C in cell adhesion assays. T he 
results indicate that tenascin-C is a poor adhesive substrate for 
cultured keratinocytes. 
MATER1ALS AND METHODS 
Cells and Culture Conditions T enascin-C production was examined in 
hU111an glioblastoma and osteosarcoma cell lines and in primary cultures of 
epide rmal keratinocytcs and dermal fibroblasts. The human glioblastoma 
cell lines U87-MG, U138-MG, and U373-MG were provided by R . 
Verstraeten (Free University of Amsterdam, T he Netherlands), and Saos-2 
sarcoma cells wcre a gift fi'om E. Mackie (I<.oyal Veterinary College, 
London , United Kingdom) . T he ce ll lines arc available from the American 
Type C ulture Collection (Rockville, MD) as HTB14, HTB16, HTB17, and 
HTB85, respectively. All cultured cells were tested negative for myco-
plasm a . 
CeU lines and dermal fibrob lasts were grown in Dulbecco's modified 
Eagle's medium (DMEM)/F-1 2, 3:1 (vol/vol), suppleme nted with penicil-
lin (100 units per ml) plus streptomycin (100 !kg per ml) and 10% fetal 
bovine serum . Human keratinocytes from skin biopsies of hea lthy donors 
were initially cultured by the m ethod of Rllcinwa ld and Green (1975). 
Keraci.nocytes fi'om thesc cultures were again seeded on a feeder la yer of 
irradiated 3T3 ce lls or, alternatively, in serum-free medium. For the method 
ofRheinwald and Green, DMEM/ F-12 , 3:"1 (vo l/vo l), supplemented with 
0.4 J.Lg hydrocortisone per ml , 1 !kM isoproterenol, 10 ng ep idermal growth 
factor per ml , 6% few I bovine serum, 100 uni ts penicill in per m l, and '100 !kg 
streptomycin per 1111 was used. Scnull-frec cul ture nlCdiuI11 was keratinocytc 
growth medium (KGM). KGM was composed of keratinocyte basal me-
dium (Clonetics, San Diego, CA; 0. 15 mM calcium) supplementcd with 0.1 
mM e thanolamine, 0 . .1 M phosphocthanolaminc, lOng epidermal growth 
factor per ml, 5 !kg insulin per ml , 0.4% (vollvo l) bovine pituitary extract 
(Clon e tics, San Diego, CAl, 0.5 !kg hydrocortisone pcr m1. 100 units 
penicillin per ml, and 100 !kg streptomycin per ml. 
Before reaching conflucncy , the serunl concentra tion of serUlll-contnin-
ing m edium was lowered to 1 %. After 3 d, medium was collected and 
tenasc in-C concentrations were determined by an enzyme-linked ill1mu-
nosorbent assay (ELISA). 
In Vitl'O Reconstrllction of Epidermis 011 De-Epidermized Dermis 
(OED) Keratinocytcs cultured by the mcthod of RllCi nwald and Green 
were seeded on DED and cultured in DMEM/ F-1 2 , 3:1 (vol/vol), supple-
mente d with 5% HyClone newborn bovine serUlll (Greiner, Alphen aid 
Rijn , T he Netherl ands) , 0.4 /-lg hydrocortisone per ml. '1 !kM isoproterenol , 
and 5 !kg insulin per ml. Cultlll"cS we re maintaincd submerged in the 
medium for 3 d and then were ai r-exposed for another 3-14 d. The nledium 
used for air-exposed culture was supplemented with lOng epidermal 
growth factor per ml. Generation of DED and culture mcthods have been 
described previously (Prunieras el III, 1983; Ponec, 1991). 
Biopsies Experimental wounds were made by taking partial thi ckness 
punch biopsies with a diameter of 3 ITnn from the upper arm of hea lthy 
HUMAN KERATINOCYTES ARE A SOU R.CE OF TENASC IN - C 777 
volunteers. Fu ll-thickness punch biopsies with a di am eter of 4 111m w ere 
taken fi'om the difFerent wounds after 2, 4, 7, 14, 60, and 365 d. These 
secondary biopsies, which included the hea ling wounds and some of the 
adj acent normal skin , were embedded in Tissue Tek OTC compound and 
stored at -80e C until use or were formalin-fixed and embedded in paraffin . 
Penniss ioll for expcruncnts on hlun31ls ,vas o bta.i ned fr0l11 dlC Medical 
Ethical Committee of the University Hospital in Nijmegcn. 
Antiserum Antibodies directed against human tenasc.in-C wcre d,e 
mouse mo noclonal antibodies T 2HS (for reference, see ScilaJkwijk el nl, 
1991a) and TN2 (Dako, Glostrup, Denmark) and two rabbit polyclonal 
antise rums AI07 and TN9S3. AI07 was obtained fi'om C hemicon Interna-
tional (Temecula, CAl. We rai sed TN9S3 in N ew Zealand White rabbits by 
immunization with highly purified human tcnascin-C from U1 38- MG cells. 
Traces of anti-fibronectin reactivity in TN953 were removed by solid-phase 
absorption with human fibro nectin. Antibod ies aga inst human fibronectin 
were a mo use monoclonal antibody (Sigma-Aldrich, Boruem , Belgium) and 
a rabbit polyclonal a.ntiserum (Life Teclmologies, Breda, The Nedleri ands). 
Immunohistochemistry T2HS , TN2, and TN953 were used for stain-
ing oftenascin-C in cryostat sections. 1n addition, TN2, TN9S3, and AI 07 
werc applied to detect tenascin-C in formalin-fixed sections. Staining with 
T2HS was performed by an indirect immunoperoxidase sta ining protocol 
described previously that uses 3-al1lino-9-ethylcarbazole as a chromogenic 
substrate (Scha lkwijk el aI, 1991a). For TN2 , TN953 , and AI07, the 
Vectas~ain ELite ABC kit (Vector Laboratories, Burlingame, CA) was used 
:lccordtllg to the 111anuf.lc ture r' s instructjons. \vith dianlinobenzidinc as a 
chroll1ogcnic substrate. After iI11nlU110sta.il1ing. sectio llS were counterstailled 
with hematoxylin . 
ELISA To quanti fy tenascin-C concentrations in culture medium, a 
sandwich-type ELISA was developed that is similar to the one described by 
S~henk and colleagues (1 99 5). Polystyrene microtiter plates were coa ted 
With T2H5 . After blocking free protein binding sites with bovine serum 
albumin (BSA), dilution series of samples, standard, and blanks were 
incubated in the well s, and A107 was subsequen tl y used to detec t bound 
ten~scin-C . . AI07 binding was assessed Witll peroxidase-conjugated swine 
3ntl-rabblt nllmunoglobu.! ins and o-phenylenediamine dihydroch.loride as 
the chromogenic substrate. T he color reaction was stopped by adding 4 M 
H 2S0 4 and evaluated by reacling the absorption of the color product at 490 
nm, with 655 nm as a refere nce wavelength . T he same m ethod was applied 
for the fibronectin-specific ELISA. For these a mouse monoclonal antibody 
and a rabbit polyclona.l antiserum against human fibronectin were used. 
C hicken egg ova lbumin was used instead ofBSA in the fibronectin ELISA. 
The standards used in ELISAs were human tenascin-C purified fro m the 
melanoma ceI.l line SK-MEL-28 by L. Zardi (Institll to Nazionale per la 
Ricerca su i C ancro, Genoa, Italy) and fibronectin fi'om human plasma (0.1 % 
solution , Sigma-Aldrich, Bornem , Belgium) . T he detection limits were 
approximately 20 ng tenascin-C per ml or 80 ng fibron ectin per ml. 
respectivcl y. 
Constru ction of Plasmids and Synthesis of RNA Probes Tota l 
RNA was isolated fj'om cultured human derma.! fibrob lasts, and cDNA was 
synthcsized by reverse transcription Witll o ligo (dT) primcrs. Part of the 
cD NA was amplifi ed by using a polymerase chai n reaction and subcloncd in 
pGEM-3. Thc tenascin -C- coding insert corresponds to nucleotides 6016 -
6475 of the human tcnascin-C cDNA sequence as submitted by Gherzi and 
collea~ues to the EMBL Database Library (accession number X78565) , 
span!llng part of the most C-terminally locatcd fibroncctin type III rcpea t 
and part of the fibrinogcn-like domain . 
T he plasI11id was lin ea ri zed , vith Balli HI to synthesize an anti-sense 
complementary KNA probe by using T7 polymcrase and with EcoID to 
syntheSize control sense complcll1entat), R.N A by using Sp6 polYll1cnise in 
thc reverse orientation. Dioxigenin (D IG)- Iabcled anti-sense and sense 
probes were synthesized by using a Sp6/T7 ;11 ,' ;11"() RN A synthes is kit in the 
presence of D IG-UTP (Boehringer Mannheim , Mill1nheim, Germany). 
SyntheSIS was performed at 3 rc with T7 polymerase and at 40e C with Sp6 
polymerase. T he anti-scnse probe thus prodnced was 471 nucleo tides long, 
and the senSe probe was 498 nuclcotides long. 
[II Sit" Hybridi zation I II S;III hybridization was performed on frozen 
sections as described (Pfundt el nl, 1996) with the modifi cation that d,e 0.1 X 
sodium citrate/ chloride bufFer used to wil sh slides after hybridization 
contained 600/.1 fOrnlall1jde instead of 500/0. O ptinlal pro be concentratio ns 
were dete rmined in a pilot experimcnt: 200 ng pe r ml was choosen for 
further use. H ybridization was assessed with Fab fi'agme nts of sheep 
anti-D IG monoclonal antibodies conjuga tcd to alkal.ine phosphatase 
(Boehringer Mannhcim) and subsequent sta ining with n.itro blue tetra zo-
lillln and 5-bromo-4-chloro-4-indolyl phosphate. 
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Tcnascin-C Purification U138-MG was used for tenascin-C purifica-
tion. Before the ce ll s rcached conAuency, the serum conccntration of the 
medium was lowered to 1 % fetal bovine serum and cultllJ'es were main-
tained for an additional 2 1110, during which 111CdiuI11 was collected every 3 
or 4 d for tcnascin-C purification. Protcinase inhibitors (2 mM ethylenedi-
amine tetraacetic acid, 0.3 mM phenylmcthylsulfonyl fluoride, and 2 ILg 
aprotinin pel' ml) and 0.05% NaN, were added to the collected medium. 
The medium was subjected to two rounds of anion-exchange chromatog-
raphy. First, tenascin-C was elu ted from hydroxylapatite in a batch wise 
manner with increasing concentrations ofNa2HPO.,0·12H20. The fractions 
that contained most of the tcnascin-C were used for final purification on the 
Smart System using a Mono Q HR 5/5 column (Pharmacia, Uppsala , 
Sweden) and a gradient of 0.1-1 M NaCI in 20 mM Tris(hydroxymethyl) 
amillomethane (pH 7.9). In this way, tenascin-C could be qmllltitatively 
separated from fibroncctin (see Fig 6). The concentration of purified 
tenascin-C was quantified by ELISA. Q ualitative analysis included fibroncc-
tin specific ELISA and western blotting. In addition, thc hemagglutinating 
activity of the tenascin-C preparations was verified (Erickson and Inglesias, 
1984; Chiquet Ehrismann et ai, 1986). On western blots of reduced 
tcnuscin-C, sped_fie antiserUI11 stained twO tcnascin-C bands with l1101ecular 
weights exceeding 200 kDa. The only contaminating proteins were traces of 
fibronectin and BSA: laminin was not detected. According to ELISA results , 
the purified tcnascin-C typica lly contained less than 3% fibroncctin. 
Cell Adhcsion Assays Adhesive proteins used in the adhesion assa ys 
were fibronectin from human plasma (0.1 % solution , Sigma-Aldrich, 
Bornem, Belgium), lamin;n purified from human placenta (Life Technolo-
gies, Breda , The Netherlands), tenascin-C purified from the gliobhlstoma 
cell line U251-MG (Chemicon International , Temecula, CAl, and human 
tenascin-C that we purified olll'seives fi·om the glioblastoma ce ll line 
U138-MG. Polystyrene microtiter plates were coated by in cubation over-
night at 4°C with 50 ILl of a solution containing the appropriate protein 
diluted in Du lbecco 's PBS (DPBS = PBS containing 0.9 mM CaCl2 • 2H2 0 
and 0.49 mM MgCl2 • 6HzO) . Unbound protein Wil S removed by washing 
with DPBS and free protein binding sites were blocked by incubation for 1 h 
at 37°C with DPBS containing 1% BSA. 
For adhesion assays only secondary cultures of keratinocytes were used. 
Cells from subconfluenr keratinocyte cultures wcre harvested by trypsiniza-
tion and subscquently resuspended in DPBS with 5% fetal ca lf serum to 
inactivate trypsin. In cases where keratinocytes had been cultured according 
to the method ofRheinwald and Green, the feeder cell s were rcmoved with 
ethylenediamine tetraacetic acid prior to trypsinization. After two washes in 
succession with DPBS and DMEM supplemented with 0.25% BSA and 20 
niM HEPES (pH 7.4), cell s were resuspcnded in DMEM, 0.25% BSA, and 
20 mM HEPES (pH 7.4) and seeded into the wells (5000 -1 0,000 cells per 
well) . Cells were allowed to attach for 2 h at 37°C in a 8% CO2 humid 
atmosphere. Non-adherent cell s were removed by washing with 200 ,.d 
DPBS per well until the ce lls in the BSA-coated control wells were 
sufficiently removed as monitored by visual inspection. Typically this took 
3 washes. The attached cells were fi xed with 3.8% phosphate buffered 
fonnalin and stained with 0.5% toluidine blue. Attached cells were counted 
directly 01' quantified by measurement of the absorbance at 655 nm after 
solubilizing the cell bound toluidine blue in 100 ILl cetramide buffer (0.4% 
cetyltrimethylammoniumbromide, 0.1 M Tris(hydroxymethyl)aminometh-
ane (PH 8.5), 1 M NaCI). The number of cells was read fi'om a ca libration 
curve that was obtained by plotting the number of cells as determined by 
directly counting against the absorbance measured. 
Phorbol esters can stimulate integrin ligand-binding capacity of integrillS, 
presumably by inducing conformational changes (Diamond and Springer, 
1994) . In adhesion-stimulation assays, keratinocytes were, therefore, seeded 
in tile presence of 25 nM phorbol 12-myristate 13-acetate (PMA, Sigma-
Aldrich, Bornem, Belgium). In inhibition assays, antiserum was used to 
block the coated adhesive protein before seeding the cells by incubating 
coated wells with a satmating concentration of the appropriate antiserum in 
DPBS with 1 % BSA for 1.5 h at 37°C. 
All assays were performed at least in duplicate, and in individual assays , 
triplicate or quadruplicate wells were used for each assay condition. 
Adhesion results were donor-independent as comparable resu lts were 
obtained with keratinocytes of different individuals. 
RESULTS 
Tenascin-C Production by Cultured Cells To investigate the 
ability of several cell lines and primary cultures of human skin cells 
to produce tenascin-C, the tenascin-C concentration in the condi-
tioned medium was assessed by a sandwich ELISA. Results are 
summarized in Table I. In the unconditioned culture medium, no 
tenascin-C was detected. Glioblastoma and sarcoma cell lines 
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Table I. Tenascin-C Is Detected in the Conditioned 
Medium of Tumor Cell Lines and Cultured Normal Skin 
Cells by ELISA 
Cell Type 
U87-MG 
U138-MG 
U373-MG 
Saos-2 
Dermal fibroblast 
Epidermal keratinocyte" 
Epidermal keratinocyte' 
TN-C Concentration" 
(ILg/m l) 
2.07 ± 0.74 
5.22 ± 0.07 
2.28 ± 0.19 
1.12 ± 0.24 
1.04 ± 0.13 
0.49 ± 0.06 
0.21 ± 0.07 
" O:1t:\ arc dupli c<l te tcnascin m e;lsurCIllCIHS (ELISA). Compnrabl c results were 
obtn incd for differenr cultures of the S;lI1l C cell types. TN-C , [cnascin-C. 
I, C ltlcurcd according ro rhe: me thod of R hcinwa ld alld Green. 
r Serum-free cuimfc in KGM. 
secreted large amounts of tenascin-C, as was reported previously 
(Erickson and Bourdon , 1989; Mackie and Tucker, 1992), and of 
these, U138-MG was chosen as producer cell line for tenascin-C 
that was used in adhesion assays. Medium of dermal fibroblast 
cultures contained tenascin-C as well. Remarkably, te nascin-C was 
also detecte d in the m edium of epidermal keratinocytes, cultured 
on a feeder layer of irradiated mouse fibroblasts by the m ethod of 
Rheinwald and Green or in the serum-free medium KGM. WestenJ 
blot ana lysis of tenascin-C in the supernatants of cultured kerati-
nocytes under reducing conditions revealed the presence of two 
immunoreactive bands with molec ular weights greater than 200 
kDa (data not shown) . It sho uld be noted that because of differences 
in cell number and medium volume in the various cultures , the 
absolute amounts of tenascin-C produced cannot be compared 
directly. 
Tenascin-C Deposition by Keratinocytes Cultured on DED 
We used an ill lIi//'o model for reconstructe d epidermis to investigate 
whether tenascin-C is also produced in a culture model that allows 
full stratification of the keratinocytes and to analyze whether 
tenascin-C is deposited in the extracellular matrix or is only 
secreted in tbe medium. In this m odel keratinocytes are seeded on 
DED. The DED is prepared for culture in such a way that no viable 
ce lls remain in the tissue. This was confmned by hematoll:ylin 
staining of DED, which demonstrated that no nuclei were present 
in the DED. Immunohistochemical sta.ining of DED with tenas-
cin-C antiserum (T2HS, TN2, A307, and TN953) was virtually 
negative. When keratinocytes were seeded on a layer of DED, 
however, marked ten3 scin-C staining was observed in the DED. 
indicating that the keratinocytes produce tel1ascin- C that is depos-
ited in the DED underneath. Tenascin-C was detected after 3 d of 
submerged culture, when the cultures resemble a squamous non-
keratinizing epithelium. Tenascin- C remained present at the der-
mal-epidermal junction during subsequent air exposure, which 
induces terminal differentiation of the keratil10cytes as indicated by 
the formation of a stratum corneum (Fig 1). 
Keratinocytes Express Tenascin-C during Wound Healing 
In a previous study, we described tenascin-C exp ression in healing 
wounds during a 14-d time course and its relationship with 
epidermal hyper-pro liferation (Latijnhouwers e/ ai, 1996). We now 
have extended the time course to 1 y, and instead of one polyclonal 
tenascin-C antiserum (i.e., AI07), we have now used a panel of 
monoclonal antibodies and polyclonal. antiserum in combination 
with a more sensitive staining protocol, which indicates that the 
expression levels of tenascin-C in healing skin wounds are much 
higher than previously anticipated. In addition to the known 
increase of tenascin-C expression in the papillary dermis at the 
wound margins, we noticed a thin discontinuous line of staining 
beneath migrated keratinocytes. Both with the polyclonal anti-
serum and the monoclonal antibodies, deposition of tenascin-C in 
the wound bed was observed beneath the entire sheet of migrating 
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Figure 1. Kcratinocytcs culturcd on DED dcposit tcnascin-C in thc 
denn.is undernea th. Tenascin-C is detected il11lllunhistochellli cally w ith 
the monoclonal T N 2 in a culture that waS maintained submerged for 3 d and 
subsequently air-exposed fo r 10 d . COllnterstaining was performed w ith 
bematoxylin . ded, OED; e, reconstructed epidermis. Sen!e bnr, 100 iJ-m. 
keratinocytes, including the lea ding edge. Examples o f wounds 
afteL 2 and 4 d are show n in Figs 2A and 3A, respectively. W hen 
re- epithelialization was complete (day 7, shown in Fig 4A), 
tenasci.n -C WaS detected in the dermis not only at the dermal-
epid ermal juncti on but also in the granul ation ti ssue. At day 14, 
tenascin-C still con tinuously lined th e neo-epidermis and was even 
mOLe abundant in th e granulation ti ssue th an at day 7 (Fig SA,B). 
Tenascin-C staining patterns in older wounds varied considerably, 
in som e of the wounds, tenascin-C regained its normal patchy 
staining pattern at the dermal- epiderm al junction with.in 60 d, 
whereas in others tenascin-C w as still increased after 1 y. In these, 
tenasci.n-C was continuous at the dermal-epidennaljunction and in 
some cases pronounced staining of part of the scar tissue deep in the 
dermis was observed. 
In addition to the dermal tenascin-C staining, we observed 
granular staining of tenascin-C in the sheet of migrating keratino-
cytes and in the neo-epidermis with all rypes of antiserum tested. 
Although such staining was found even 2 d after wounding, it was 
most pronoun ced after wound closure at days 7 and 14 (Figs 2A; 
3A; 4A; SA,B) . T hese data strongly suggest that tenascin-C in the 
wound bed and in the papillary dennis of the closed w ounds is at 
least in part derived from the epidermal keratinocytes. T o examine 
this at the mRNA level, we performed ill sitll hybridiza tion. A 
construct was made to synthesize anti-sense and sense complemen-
tary RNA probes of approximately 500 nucleotides. H ybridiza tion 
of th e DIG-labeled probes was assessed immunohistochemically. 
Op timal probe concentrations were determined in a pilot experi-
ment . At a concentration of 200 ng per ml , strong hybridization 
signals were obtained with the anti-sense probe, w hereas no 
staining was observed in control sections hybridized with the sense 
prob e. In normal unwounded skin, no tenascin-C mRNA was 
detected. During the initial phase of wound healing, tenascin-C 
mRN A was detected in basal cells of the sheet of migrating 
kera tinocytes and only sporadically in dermal cells (Figs 2B, 3B) . 
At this point there are few dermal cells present in the wound area, 
and although the percentage of dermal cells that hybridized w as 
h.igh immediately beneath the wound, far more hybridizing cells 
were observed in the epidermis. As re-epithelialization proceeded, 
the number of basa lly located keratinocytes that express tenascin-C 
mark edly increased , reaching a maximum at day 7 when the wound 
was closed (Fig 4B) . At tllis stage granulation tissue was formed 
and numerous tenascin-C positive cells (presumably fibroblasts and 
endothelial cells) were found in the wound bed. By day 14, 
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tenascin-C mRNA was only sporadically detected: hybridization of 
the an ti-sense probe to few keratinocytes in th e basal layer of th e 
neo-epidermis and to some derm al cells was observed (Fig sq. 
Keratinocytes Do Not Adhere Well to T en a scin-C Other 
investiga tions have shown that tenascin-C in flu ences adhesion of 
various cell types i ll lI ilm (Clliquet Ehrismann et II I, 1988; Fried-
lander et II I, 1988; Lotz et II I, 1989; Spring ei Il l, 1989; Lightner and 
Erickson , 1990; Murphy Ullrich et Ill , 199 1; Prieto et III, 1992, 
1993). W e now performed adhesion assays with cultured keratino-
cytes to inves tigate whether tenascin-C modulates adhesion of 
kera tinocytes as well. For that purpose, human tenascin-C was 
purified from the culture medium of U138-MG glioblas toma cells 
by two rounds of ion-exchange chromatography. Silver staining of 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels 
showed that fin al preparations contained almost exclusively tenas-
cin-C, whereas the commerciaUy ava ilable tenasciu- C contained 
considerably more contaminating proteins (Fig 6) . R otary- shad-
owed electron microscopy of our purified tenascin-C revealed the 
presence of tenascin-C m onomers and hexam ers (data no t shown). 
T he culture condi tions turned out to be critical for adhesion 
properties o f the keratinocytes. In general, KGM-cultured kerati-
nocytes were less adhesive than keratinocytes of the sam e donor 
cultured on a feeder layer of mouse fibroblasts by the method of 
Rheinwald and Green (Fig 7) . \l(1hen KGM-cul tured keratinocytes 
were seeded , typically only:±: 20% of the cell s adhered to fib ronec-
tin; w hen feeder-cultured keratinocytes were seeded , approxi-
mately 40% of dle ceUs adhered. In the presence of PM A, adhesion 
of KGM-cultu red keratinocytes to fi bronectin markedly increased 
up to 60%; in contrast , PMA had littl e effect on adhesion of 
feeder-cultured keratinocytes. N o adhesion to tenascin-C was 
observed with KGM-cultu.red keratinocytes (Fig 7) . Feeder-cul-
tured keratin ocytes, however, did adhere to tenascin-C (Figs 7, 8) . 
Aldlough the numbers o f attached cells were low, valu es exceeded 
those obtained with BSA alone in all experiments. Furthennore 
adhesion of feeder-cultured keratin ocytes on tenascin-C was con~ 
cen tration-dependent, and PMA increased adllesion to som e ex-
tent. Coating of the commercially available tenascin-C resulted in 
significantly more adhesion d13n coating of our own tenascin-C 
?reparation . T llis is m ost likely due to the h.igh level of impuri ties 
111 the commercial prepara tion, w llich contains lamin in among 
other tllings. T he keratinocytes that adhered to tenascin-C had a 
morphology different from that of the cells dlat adhered to fi -
bronectin or laminin . M ost of the cells on fi bronectin and laminin 
spread after adhesion , but the few cells dlat adhered to tenascin-C 
remained more rounded (Fig 9). 
To test the s.pecifici ry of t~l e tenascin-C binding, we attempted 
to blo.ck keratmocyte adh~slon to tenascin-C by pre-incubating 
tenascm-C- coated wells With sa tura ting concentrations of tenas-
cin-C polyclo~lal antiserum Ai 07 or TN953. For comparison , a 
polycl onal anbserum against human fibronectin was used to block 
fi bronectin binding. In such adhesion inllibition assays, fibronectin 
binding was significantly and specifica lly inllibited . N eidler an ti-
tena~cin-C polyclonal serum, however, could significantly and 
specificaUy block .ad~esion to tenascin-C (data no t shown) , casting 
doub~ on the specificlry of the interaction between the few adhering 
keratmocytes and tenascin-C. 
DISCUSSION 
T enascin-C expression varies considerably in human skin . In 
normal skin, tenascin-C is sparsely diso'ibuted , but its expression is 
markedly upregulated in conditions of epidermal hyper-prolifera-
tion . Because tenascin-C is generally found in connective ti ssues it 
is assumed that dermal tenascin- C is derived from mesench~al 
cells. H erein we show , however, that in skin tenascin-C can be 
produced by epidermal keratinocytes as well . We inves tigated 
tenascin-C production of skin cells ill llitm and ill vi llO. O ur i ll Ilitm 
data indicate that cultu red keratinocytes secrete tenascin-C in to the 
medium . T hey do so w hen cultured on a feeder layer of irradiated 
3T3 m ouse fibrobl as ts by th e method of Rheinwald and Green or 
Figurc 2. Tcnascin-C in serial scctions of a human skin wound after 2 d . Tenascin-C express ion was assessed by immullollistochemica l stai.ning wilQ 
T2H 5 (A) and ill silll hybridizatio n w ith D IG-labeled an ti-sense (B) and sense (C) probes. Tcnascin-C protein shows a continuo us pattern at tb~ 
dermal- epidermal junction and in addition is stained beneath migrated kcratinocy tes. Tenascin -C mR.NA is dCl11onsO"llted in some dermal cells but is most 
prominent in migrated keratinocytcs (B) . Sections arc cOu l1 terstil ined with hematO),-y lin (A) or methyl green (B,C). Scale !Jar, 100 fLJ11. 
Figure 3. Ten3scin-C in serial sections of a hurnal1 skin wound after 4 d. Tcnascin - C protein is detected i\l1\11un ohistochemica ll y with T2H5 at th~ 
dcnl1al-epidermal junction of the wound margin , beneath the neo-epiderm is, and sporadic;dJy in the migrated keratinocy tes themselves (AJ. Nonradioactive 
i" silll hybridization "evea ls that tenascin-C mRNA is main ly el<pressed by basall y loca red ker<ltinocytes o f the neo- ep idermis; dermal cell s are only 
sporadi cally sta ined (B). For comparison hybridization o bta ined with the control sense tcnascin-C probe is shown (C) . Sections are counterstained \\~ th 
hema toxylin (fI) or merh yl green (H,C). Scale !Jar, 100 J..L111 . 
F igure 4. Tenascin-C ill serial sectiolls of a human skin wound after 7 d. Tenascin-C pro tein continuously lin es the neo-epidermis of the closed 
wound (fI) and is detected w ithin the nco-epidermis. To detec t tenascin-C prote in immunohistochemical swining w ith T2H S W;lS performed, and the section 
waS counterstained w ith hematoxylin. Hi.gh levels o f te l1ascin-C mRNA are found ill the basally Joc"ted keratilloc),tes of the nco-epideu]]js (B) by ill sin, 
hybridization with a D IG-labeled anti-scnse probe . As a contro l, hybridization with the sense telJascill-C pro be was performed (C). Sectjons shown jn Band 
C were cOllntersta ined w ith methyl green. Scale !Jar, 50 p.m . 
F ig ure 5. Tenascill-C ill sedal sections of a human sl<in wOlll1d after 14 d. T enascin-C is abundant at the protein level; llla ss ive illllllLlnohisto-
chemic,,1 sta in ing is observed in the granu lation tissue (fI), and in tbe nco-epidermis, " marked grantlla,. staining is obse rved (B). III sitll hybridization wjth 
a D 1G- labeled anti-sense probe shows that tellascin-C mRNA ( -~), however, is only sporadi ca ll y detected (C). T2H 5 was used for imll1l1nhistochel11.ic:tl 
sta ining (A,B) and sections were cOllntersnlincd with hematoxylin (A,B) or methyl green (C). Senle bars: (A) 200 fLl1l ; (B) 50 lun ; (C) 100 fLll1. 
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Figure 6. Tenascin-C purification. Silver stai ning of a 4 - 20% gradient 
gel e l ecrropho rc,ed under reducing co ndi tioll s. Lnlle 1. culturc m edium of 
U138-MG cell s; Inllc 2, fi'a cti on elutcd frO I11 hydroxylaparite; Ia/ ," 3. fraction 
of the Mono Q co lumn containing fibronectin and nSA; In lie 4, final 
tenasci n-C preparation after sepa ratio n on the Mono Q co lumn; Inlle 5 , 
cornn'1ercia lly ,Ivaila ble tcn3scin-C ; lane 6, mo.lecular \-veighc Jll arkers. 
when they are cultured without feeder in serum-free m ediulll , 
indicating that serum- or feeder-derived facto rs are not necessary to 
induce tenascin-C production . Immunohistochemical analysis of 
reconstructed epidermis showed that keratinocytes ill lIilJ'() are able 
to deposit tenascin-C in the extracellular matrix as well. Tenas-
cin- C was detected in cultures that were maintained submerged in 
the culture medium for 3 d and remai ned present during subsequen t 
air - exposed culture. Whetller this is ca used by continu ed tenas-
cin- C expression or slow turnover of previously made protein 
cannot be concluded from tllese immunohistochemical data. In ter-
es tingly, the site of tenascin-C deposition, namely the derl11al-
epid ermal junction of the cultures, corresponds to the location of 
cenascin- C ill lI il'o. T hese ill lI ill'O models, the monolayer keratino-
eyte c ulture sys tems and the reconstructed epidermis, sho uld be 
useful when further investiga ting the regulation and effec ts of 
epiderm al tenascin-C expression. 
The finding that ke ratinocytes express tenascin- C ill lI il J'() is 
clearly relevant for the ill lIillo situation , as we could detect 
tenascin- C in the epidermis of healing skin wounds at the protein 
and the mRNA levels. Epidermal tenascin-C expression was pre-
viously demonstrated in feeder-cultured human keratinocytes I and 
in an'lphibian epidermis (Onda el aI, 1991). Recently, Aukhil and 
colleagues (1996) reported on tenascin-C expression by keratino-
cytes during heaUng of incisional wounds i.n rats where they 
observed expression patters similar to wh;Jt w e found in human 
tissu e. In a previous report we concluded that keratillocytes cou ld 
potentia lly .interact with tenascin-C in the later stages of wound 
healing but were unlikely to come in to contact with tenascin-C in 
the early phase beca use of the undetectable levels of tenascin-C 
under the migrating keratinocytes (Latijrthouwers cl al, 1996). \Xfe, 
however, have now used a panel of polyclonal and monoclonal 
antibodies co mbined with a mllch lllo re sensitive stai ning prorocol 
that indicates that the expression levels of tenascin-C are mu ch 
higher than previously anti cipated. In this study we cou ld detect 
tenascin-C in the dennis underneath the migrating keratinocytes. In 
addition , keratinocytes themse lves are stained fo r tenascin-C pro-
tein. III s;11I hybridization results indicate that in the early phase of 
wo und healin g, before wound clOSlIre, keratinocytes of the neo-
epidermis are the major source of tenascin-C. By the time that the 
wounds are closed, tenascin-C production in the neo-epidermis is 
J Lightne r VA and Singer H: C ui tlll'ed ke ratinocytes synthesize hexabra-
chio n ltenascin. J illl'CS( O l'rl/lfl/ol 92:471. 1989 (nbstr). 
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F igure 7 . Adhesion to fibronectin a nd tenascill- C of keratinocytes 
cultured in KGM or by the m ethod ofRheinwald a nd Green . Assays 
w ere performed with (_) o r w ithou t (0 ) PMA . Adhesion w.ithour PMA 
,vas perfornlcd in trip licate or quadrupli cate in six e Xpet;nlents, and the 
effect of PM A was tested six and three times for feeder-cu ltured and 
KGM- cultured cell s, respective ly . R epresentative data fi'ol11 one of these 
experimeJ][s are shown. En ol' bnrs, SEM (n = 3) . 
accompanied by abundant dermal renascin-C expression in the 
granulation tissue. Subsequently mRNA synthesis decreases: at day 
14 after wounding very few cells in either the dermis or the 
epidermis ex press tena scil1-C mRNA . In con trast, ten:1scin-C pro-
tem lS most abundant at day 14, indicating that maximum protein 
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Figure 8. Adhesion of feeder-cultured keratil1ocytes. A comparison 
is Illade be tween adh esio n to laminin (LN) , Iib"oncctin (FN). commerc iall y 
a":lIl able human tenascin-C (TN com). and tcn ascin-C that we purified 
fi·orn h Ull Ian g liob lastolll<l cd Is (TN). Pro te ins w e re coa ted at a concentra-
tion of 20 fLg pCI' m l, except for purified tenasc in -C , wh ich w as used at 4. 
20. and 100 j.lg per 1111. Adhesion wi th our PM A (0 ) was compared to 
adhcsio n in the presence of PM A (_). O ne representative experiment o[ si" 
separate expe rim ents is shown. Error bars . SEM [11 = 4 (LN and FN) or 3 
(TN COIn and TN)] . 
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Figure 9. Kcratinocyte morphology in adhesion assays . Values 
indiclltC the percentages of the attached feeder-cultured kerutinocytes that 
h"ve sprc"d. I)at" were obtained from three or fOllr separate experiments. 
Ernll' hal's, SEM [laminin (LN) and fibronectin (FN), n '= 12 (without PMA) 
and 11 '= 5 (with PMA), respective ly; tcnascin-C (TN), n = 12 in both 
conditions]. 
levels are reached later than maximum mRNA levels and that the 
turnover of tenascin -C in the wounds is rather slow. 
Because tcnascin-C is detected beneath the migrating keratin o-
cytes that do not encounter an intact basal membrane stru cture 
(Latijn houwers el ai, '1 996), we wondered whe ther it may function 
as a kind of provisionary mOltJ'ix to which these keratil10cytes 
adhere. T he results of th e adhesion assays indicate that keratino-
cytes adhere poorly to tenascin-C. T herefore, tenascin-C does not 
seem to be an important adhesive substrate for keratinocytes. A 
prereq uisite for tenascin-C having a direct effect on ke ratinocytes is 
interac tion between keratinocytes and tenascin-C, w hich is most 
likely receptor- mediated. In the adhes ion assays, very few kerati-
nocytes remained attached to ten<lscin-C, suggesting that interac-
tions between such putative receptors on keratinocytes and ten as-
cin-C are not very strong. It shou ld be noted, however, that strong 
intracellular effects ma y be evoked in spi te of weak receptor 
binding. T his was recently reported for the in teraction between 
fib ronectin and (Xv integrins (Schwartz and Denl1ingholf, 1994). 
Although fib ronectin binding to th ese receptors is much weaker 
than binding to a sf3, , the former in teraction evokes the rise in 
intracellular Ca 2 + that was observed in cells that adhered to 
fi bronectin. 
Although tenascin-C does not m ediate strong keratinocyte ad-
hesion, it may well affect adhesion of keratinocytes to other 
proteins. It is known, for example, that tenascin-C inhibits fi -
bronectin adhesion of various cell s (Lotz ef ai, 1989; Lightner and 
Erickson, 1990; Murphy U llrich ef ai, 1991; Prieto et ai, 1993). 
M odulation of keratinocyte adhesioll might be a major function of 
tenascin-C il7 vivD. T his may be especially important during wound 
healing, w here keratinocytes have to migra te to close the wound. 
Tenascin-C might facili tate keratinocyte migration by weakening 
the adhesion to fibronectin and pOSSibly other extracellular matrix 
proteins that could otherwise interfere with keratinocyte migration 
and subsequent wound closure . Modulation of keratinocyte adhe-
sion by tenascin-C is likely to be receptor-mediated. In the 
literature, various tenascin- C receptors have been described (Bour-
don and Ruoslahti, 1989; Sahnivirta ef ai, 1991; Prieto et aI, 1993; 
Sriramarao et ai, 1993; Barnea et til, 1994; Chung and Erickson, 
1994; Vaughan el ai, 1994; Yokosaki el aI, 1994; Varnum FilU1ey et 
ai, 1995), and of these, the (1)36 integrin is an interes ting candidate. 
Keratinocytes normally do not express Ci v /3" but expression is 
induced ill "irl'o after subculturing of keratinocytes and ill vivo Ci v /36 
is expressed by wound keracinocytes (13reuss el ai, 1995; Haapasalmi 
el (I I, 1996). T he site of Ci v /3r, expression , namely, the basal 
keracinocytes of the neo-epidermis, and the level of a v /36 expres-
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sion coincide with the site and leve l of tenascin-C expression. 
R eceptors o ther than ovf36 could also bring about adhesion mod-
ul ation by tenascin- C, such as the f3 , integrins. Expression of {3, 
integrins generally is strongly upregu lated in wounds (Grinnell, 
1992; H ertle et ai, 1992; La.ljava el ai, 1993; Watt and Jones, 1993) 
and vario us f3t integrins are able to bind ten ascin-C (Bourdon and 
R uoslahti, 1989; Prieto et ai, 1993 ; Sriramarao el ai, 1993; Yokosaki 
et ai, 1994; Varnum Finney et ai, 1995). Among the non-integrin-
type tenascin-C receptors described, syndecan and annexin II could 
be importan t (Salmivirta el (II, 1991 ; Chung and Erickson, 1994). 
Th e expression of the membrane bound proteoglycan syndecan is 
altered during wound healing in the epidermis and the granulation 
tissue, the sites w here we found changes in tenascin-C expression a 
well (Elenius el ai, 1991 ; Oksala el ai, 1995). Expression of the 
glycoprotein annexin II during wound healing has not been 
studied, but annexin II is present on the surface of keratinocytes ill 
lIitro and ill lIillo in normal and pathologic conditions (Culard et ai, 
1992; Bastian et at, 1993; Ma el 111, 1994) . Moreover, recent findings 
of Chung el al (1996) support the idea that annexin II could have a 
major ro le in tenascin-C-mediated effects 011 cell migra tion. 
W e conclude that keratinocytes are a major so urce of ten1lscin-C 
in the early phase of normal human wound heal ing, and we 
hypothesize that te l1 ascin- C may have an anti-adhesive effect on 
keratinocytes . 
M?e (//(J"k j oop /(cmpclf(f(1" rllld Gijs de }cmgh for e~t.·{ellelll (ecJmical assisll7J1fC, lind 
Erik Daile/( .1"1' Iris " (flllrlble (fd"ice 1'~~rI,.dill,~ lire adlresioll rlssa ),s. HIe are a/so 
if/debted to R f/d, C hiqllet Ehl'islll flllII, ",h" fmfor!ll ed "'l'etl'Oll !IIic/'llscopJ' ~r 
l'olrlI'V-siMdo",ed tell flsrill-C fIItd I" L llciallo Zrl rdi lI,i ll! jJ,." " id(!d liS ", itlt rite 
tellrl.l'rill- C IIsed ji)r cnlibrimioll ill ELISA.,'. T his 1I,,,,.k was.fi ll rl llcia llJ' sl/p]iorted by 
f1 gran! from The {Vether/nllds Ol:~'nll ;z (l(io" Jew SciCI11!'fic R.esenrch. 
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